Janelidze, S., Collij, L. E., Mattsson-Carlgren, N., Antill, A., Laymon, C. M., Lott, I., Rosas, H. D., Minhas, D. S., Luo, W., Zaman, S., Mapstone, M., Head, E., Lai, F., Hartley, S. L., Ances, B. M., Krinsky-McHale, S. J., Lee, J. H., Ossenkoppele, R., Christian, B. T., … Hansson, O. (2025). Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study. The Lancet Neurology, 24(7), 591–600. https://doi.org/10.1016/s1474-4422(25)00158-9

Hojjati, S. H., Chiang, G. C., Butler, T. A., Chen, K., Khalafi, M., Yazdi, B. G., Foldi, N., Nayak, S., de Leon, M., Li, Y., Stern, Y., Luchsinger, J. A., & Razlighi, Q. R. (2025). Heterogeneous tau deposition patterns in the preclinical stage link to domain‐specific cognitive deficits. Alzheimer’s & Dementia, 21(5). Portico. https://doi.org/10.1002/alz.70153

Acosta Ingram, D., Turkes, E., Kim, T. Y., Vo, S., Sweeney, N., Bonte, M.-A., Rutherford, R., Julian, D. L., Pan, M., Marsh, J., Argouarch, A. R., Wu, M., Scharre, D. W., Bell, E. H., Honig, L. S., Vonsattel, J. P., Serrano, G. E., Beach, T. G., Karch, C. M., … Fu, H. (2025). GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58585-w

Mielke, M. M., Evans, J. K., Neiberg, R. H., Molina-Henry, D. P., Marcovina, S. M., Johnson, K. C., Carmichael, O. T., Rapp, S. R., Sachs, B. C., Ding, J., Shappell, H. M., Luchsinger, J. A., Espeland, M. A., & Hayden, K. M. (2025). Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity. JAMA Network Open, 8(2), e2458149. https://doi.org/10.1001/jamanetworkopen.2024.58149

Pandey, N., Yang, Z., Cieza, B., Reyes-Dumeyer, D., Kang, M. S., Montesinos, R., Soto-Añari, M., Custodio, N., Honig, L. S., & Tosto, G. (2025). Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-024-01655-w

Fowler, S. L., Behr, T. S., Turkes, E., O’Brien, D. P., Cauhy, P. M., Rawlinson, I., Edmonds, M., Foiani, M. S., Schaler, A., Crowley, G., Bez, S., Ficulle, E., Tsefou, E., Fischer, R., Geary, B., Gaur, P., Miller, C., D’Acunzo, P., Levy, E., … Ryskeldi-Falcon, B. (2024). Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease. Nature Neuroscience. https://doi.org/10.1038/s41593-024-01801-5

Boerwinkle, A. H., Wisch, J. K., Handen, B. L., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S. E., Krinsky‐McHale, S. J., Lai, F., Rosas, H. D., Zaman, S., Lott, I. T., Tudorascu, D., Zammit, M., Brickman, A. M., Lee, J. H., & Ances, B. M. (2024). The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down’s syndrome. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14359

Jones, A. A., Ramos‐Miguel, A., Gicas, K. M., Petyuk, V. A., Leurgans, S. E., De Jager, P. L., Schneider, J. A., Bennett, D. A., Honer, W. G., & Casaletto, K. B. (2024). A multilayer network analysis of Alzheimer’s disease pathogenesis: Roles for p‐tau, synaptic peptides, and physical activity. Alzheimer’s & Dementia, 20(11), 8012–8027. Portico. https://doi.org/10.1002/alz.14286

Hojjati, S. H., Butler, T. A., Luchsinger, J. A., Benitez, R., de Leon, M., Nayak, S., Razlighi, Q. R., & Chiang, G. C. (2024). Increased between-network connectivity: A risk factor for tau elevation and disease progression. Neuroscience Letters, 840, 137943. https://doi.org/10.1016/j.neulet.2024.137943

Nho, K., Risacher, S. L., Apostolova, L. G., Bice, P. J., Brosch, J. R., Deardorff, R., Faber, K., Farlow, M. R., Foroud, T., Gao, S., Rosewood, T., Kim, J. P., Nudelman, K., Yu, M., Aisen, P., Sperling, R., Hooli, B., Shcherbinin, S., Svaldi, D., … Saykin, A. J. (2024). CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-52298-2

Manzoni, C., Kia, D. A., Ferrari, R., Leonenko, G., Costa, B., Saba, V., Jabbari, E., Tan, M. MX., Albani, D., Alvarez, V., Alvarez, I., Andreassen, O. A., Angiolillo, A., Arighi, A., Baker, M., Benussi, L., Bessi, V., Binetti, G., Blackburn, D. J., … Escott-Price, V. (2024). Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia. The American Journal of Human Genetics, 111(7), 1316–1329. https://doi.org/10.1016/j.ajhg.2024.05.017

Recinos, Y., Bao, S., Wang, X., Phillips, B. L., Yeh, Y.-T., Weyn-Vanhentenryck, S. M., Swanson, M. S., & Zhang, C. (2024). Lineage-specific splicing regulation of MAPT gene in the primate brain. Cell Genomics, 4(6), 100563. https://doi.org/10.1016/j.xgen.2024.100563

Oveisgharan, S., Yu, L., de Paiva Lopes, K., Petyuk, V. A., Tasaki, S., Vialle, R., Menon, V., Wang, Y., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2024). G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults. Communications Biology, 7(1). https://doi.org/10.1038/s42003-024-06272-9

Al-Dalahmah, O., Lam, M., McInvale, J. J., Qu, W., Nguyen, T., Mun, J.-Y., Kwon, S., Ifediora, N., Mahajan, A., Humala, N., Winters, T., Angeles, E., Jakubiak, K. A., Kühn, R., Kim, Y. A., De Rosa, M. C., Doege, C. A., Paryani, F., Flowers, X., … Hargus, G. (2024). Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons. Cell Stem Cell, 31(5), 676-693.e10. https://doi.org/10.1016/j.stem.2024.03.013

Honig, L. S., Kang, M. S., Lee, A. J., Reyes-Dumeyer, D., Piriz, A., Soriano, B., Franco, Y., Coronado, Z. D., Recio, P., Mejía, D. R., Medrano, M., Lantigua, R. A., Teich, A. F., Dage, J. L., & Mayeux, R. (2023). Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity. JAMA Network Open, 6(4), e238214. https://doi.org/10.1001/jamanetworkopen.2023.8214

Yang, Y., Liang, F., Gao, J., Dong, Y., Zhang, Y., Yang, G., Soriano, S. G., Feng, H.-J., & Xie, Z. (2021). Testosterone attenuates sevoflurane-induced tau phosphorylation and cognitive impairment in neonatal male mice. British Journal of Anaesthesia, 127(6), 929–941. https://doi.org/10.1016/j.bja.2021.08.028

Hunsberger, H. C., Setti, S. E., Rudy, C. C., Weitzner, D. S., Pfitzer, J. C., McDonald, K. L., Hong, H., Bhattacharya, S., Suppiramaniam, V., & Reed, M. N. (2021). Differential Effects of Human P301L Tau Expression in Young versus Aged Mice. International Journal of Molecular Sciences, 22(21), 11637. https://doi.org/10.3390/ijms222111637

Kim, S. H., Farrell, K., Cosentino, S., Vonsattel, J.-P. G., Faust, P. L., Cortes, E. P., Bennet, D. A., Louis, E. D., & Crary, J. F. (2021). Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies. Journal of Neuropathology & Experimental Neurology, 80(9), 835–843. https://doi.org/10.1093/jnen/nlab073

Jabbari, E., & Duff, K. E. (2021). Tau-targeting antibody therapies: too late, wrong epitope or wrong target? Nature Medicine, 27(8), 1341–1342. https://doi.org/10.1038/s41591-021-01465-9